Is Sermorelin Legal in Australia? What to Know

The short answer

Sermorelin is treated as a prescription-only type substance in Australia. It is generally handled as a Schedule 4 (Prescription Only Medicine) item under the national Poisons Standard, which means lawful human supply runs through a registered prescriber and a pharmacy, not over the counter and not through general retail.

There is no finished sermorelin product listed on the Australian Register of Therapeutic Goods (ARTG) for general supply. Sermorelin is also named on the World Anti-Doping Agency (WADA) Prohibited List, so it is banned for athletes who fall under Sport Integrity Australia testing. NovaPeptides supplies sermorelin strictly as a research-use-only (RUO) laboratory material, not as a medicine and not for human use.

What sermorelin is

Sermorelin is a synthetic peptide. Chemically, it is an analogue of the first 29 amino acids of human growth hormone releasing hormone, a fragment often written as GHRH (1-29). This N-terminal fragment is widely described in the literature as the shortest portion of GHRH that keeps full activity at the GHRH receptor.

Because it mirrors a naturally occurring signalling hormone, sermorelin is categorised as a growth hormone releasing factor. In some overseas markets it was historically supplied as a prescription diagnostic and paediatric medicine under the brand name Geref, which has since been discontinued. In Australia it is viewed through the lens of medicines regulation rather than as a supplement or consumer good.

Quick chemistry snapshot

• Class: growth hormone releasing hormone (GHRH) analogue
• Structure: synthetic peptide based on the GHRH (1-29) fragment
• Category: growth hormone releasing factor / secretagogue
• Historical brand: Geref (discontinued), used overseas as a prescription agent

TGA scheduling under the Poisons Standard

Medicines and poisons in Australia are classified under the Poisons Standard, also called the SUSMP, which the TGA maintains. The schedule assigned to a substance sets out how it can be accessed and who can supply it.

Sermorelin is handled as a prescription-only type substance, consistent with Schedule 4 (Prescription Only Medicine). Growth hormone releasing hormone analogues as a class are captured under the Poisons Standard, so sermorelin is not something that can be lawfully sold to the public for human use without a prescription and professional oversight. If you need the exact current entry, the authoritative source is the TGA Poisons Standard itself.

ARTG approval status

The ARTG is the register of therapeutic goods that the TGA has evaluated and approved for supply in Australia. A listing on the ARTG signals that a product has been assessed against Australian standards for quality, safety and performance for its approved use.

There is no finished sermorelin medicine on the ARTG for general supply in Australia. In practice this means sermorelin has not been approved as a registered medicine for the public market here. Any human use would sit outside the standard registered-product pathway and would depend on specific prescriber and pharmacy arrangements, which is a clinical and regulatory matter, not a retail one.

Research material versus a medicine

It helps to separate two very different things. A medicine is a product approved or prescribed for use in people, with defined quality controls, labelling and clinical oversight. A research material is a laboratory chemical sold for in-vitro and scientific study, not for human or veterinary use.

NovaPeptides supplies sermorelin in the second category. It is offered as a research-use-only reference material for laboratory work. It is not sold as a treatment, is not presented with any health or performance claims, and is not intended to be administered to people or animals.

The schedule describes how a substance is regulated for human therapeutic use. It does not turn a research chemical into an approved medicine.

What research use only means

Research-use-only, often shortened to RUO, is a defined supply category. RUO materials are intended for laboratory and scientific investigation only. They are not manufactured, labelled or approved for diagnostic, therapeutic or consumer use.

The RUO boundary in plain terms

• Intended for in-vitro and laboratory research only
• Not for human or veterinary administration
• Not a medicine and not a dietary supplement
• Supplied with no dosing guidance and no health or performance claims
• Handled by competent researchers under appropriate laboratory controls

Keeping a clear RUO boundary matters because it reflects the law accurately. A research peptide does not become a medicine simply because it is sold, and nothing on this page should be read as encouragement to use sermorelin outside a lawful, approved context.

Sport and anti-doping status

Sermorelin is named on the WADA Prohibited List. It falls within the S2 category, Peptide Hormones, Growth Factors, Related Substances and Mimetics, under the growth hormone releasing factors grouping alongside other GHRH analogues.

Substances in S2 are prohibited at all times, meaning both in-competition and out-of-competition. For athletes in Australia, anti-doping rules are administered by Sport Integrity Australia, which applies the WADA framework. An athlete who returns a positive finding for a prohibited growth hormone releasing factor can face sanctions. Therapeutic Use Exemptions exist in principle but are assessed strictly.

Importation and legal context

Because sermorelin is a prescription-type substance, importation and supply for human use are controlled. Bringing a scheduled medicine into Australia, or supplying it to others, can engage TGA import rules and state and territory medicines and poisons laws. Research materials are a separate category, but that status does not override medicines law where a product is actually intended for human use.

The practical takeaway is that the legal position depends heavily on context: what the substance is, how it is labelled and supplied, and what it is used for. This page cannot resolve an individual situation. For anything involving importation, supply or personal circumstances, seek advice from the TGA or a qualified professional.

How NovaPeptides supplies sermorelin

NovaPeptides lists sermorelin as a research-use-only laboratory material for scientific and in-vitro study. It is not sold as a medicine, carries no dosing instructions, and is not intended for human or animal use.

What Nova provides

• Research-use-only sermorelin for laboratory use
• Novagen Certificate of Analysis (COA) available per batch for identity and purity reference
• Australian-based shipping
• No health, therapeutic or performance claims of any kind

If your interest in sermorelin relates to personal health, that is a conversation for a qualified healthcare practitioner, and lawful human access would run through the prescriber and pharmacy pathway, not through research-material supply.

Frequently asked questions